FDA’s biosimilar stakeholder submission roundup – Part II
In March 2010, the Biologics Price Competition and Innovation Act of 2009 (BPCIA) became law and established a legal pathway for the... Read More
Centocor’s ustekinumab infringes Abbott’s human IL-2 antibody patents – US District Judge
On March 9, 2012, the District Court of Massachusetts found, within a series of competing summary judgement motions, that Centocor’s ustekinumab (STELARA)... Read More